Myriad Genetics Inc
XETRA:MYD

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
XETRA:MYD
Watchlist
Price: 26.72 EUR 1.98% Market Closed
Market Cap: 2.1B EUR

Profitability Summary

Myriad Genetics Inc's profitability score is 25/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

25/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

25/100
Profitability
Score
25/100
Profitability
Score

Margins

Earnings Waterfall
Myriad Genetics Inc

Margins Comparison
Myriad Genetics Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Myriad Genetics Inc
NASDAQ:MYGN
543.7m USD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
382B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.9B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
160.4B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.1B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.9B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
86.2B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
42.6B EUR
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.2B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Myriad Genetics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Myriad Genetics Inc
NASDAQ:MYGN
543.7m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
382B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.9B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
160.4B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.1B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.9B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
86.2B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
42.6B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.2B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Myriad Genetics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate